Tag: Cellectar

The biotechnology sector is witnessing notable momentum in Cellectar Biosciences, with the company's stock demonstrating substantial upward movement following significant ...

Cellectar Biosciences finds itself navigating turbulent market conditions as its shares experience significant volatility. The biopharmaceutical company faces a complex ...

Cellectar Biosciences saw its shares advance significantly during Thursday's trading session following the company's announcement of its quarterly earnings date. ...

After a period of underperformance, Cellectar Biosciences shares are displaying initial signs of recovery. This comes at a time when ...

Investors in Cellectar Biosciences are bracing for significant volatility as the company approaches two major developments that could dramatically influence ...

Cellectar Biosciences' stock registered modest gains in Monday's trading session, advancing 1.92% to reach $5.30. This upward movement coincided with ...

Cellectar Biosciences is navigating a period of significant activity, marked by substantial advancements within its radiopharmaceutical pipeline and an enhanced ...

A significant liquidity event is unfolding for Cellectar Biosciences as a 61-day lock-up restriction on insider securities officially concludes. This ...